Literature DB >> 2118773

Rubinstein-Taybi syndrome in The Netherlands.

R C Hennekam1, M J Van Den Boogaard, B J Sibbles, H G Van Spijker.   

Abstract

This study reports the physical and radiographic characteristics of 45 patients with Rubinstein-Taybi syndrome living in The Netherlands. All had broad halluces, but only 39 patients had broad thumbs. Microcephaly was present in 35% of patients. In addition to the well-known characteristics, persistent fetal pads, a shawl scrotum, and a high frequency of fractures were found in several patients. Morbidity was mainly determined by the mental handicap, constipation, and recurrent upper respiratory infections, probably due to abnormal anatomy in the craniofacial region. Easy collapsible laryngeal walls may cause problems in sleep and anaesthesia.

Entities:  

Mesh:

Year:  1990        PMID: 2118773     DOI: 10.1002/ajmg.1320370604

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  18 in total

1.  Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300.

Authors:  Deborah Bartholdi; Jeroen H Roelfsema; Francesco Papadia; Martijn H Breuning; Dunja Niedrist; Raoul C Hennekam; Albert Schinzel; Dorien J M Peters
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

2.  Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome.

Authors:  Y Tanaka; I Naruse; T Maekawa; H Masuya; T Shiroishi; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Identification of differentially expressed genes in mouse Pax6 heterozygous lenses.

Authors:  Bharesh K Chauhan; Weiyan Zhang; Kveta Cveklova; Marc Kantorow; Ales Cvekl
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

4.  Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3.

Authors:  M H Breuning; H G Dauwerse; G Fugazza; J J Saris; L Spruit; H Wijnen; N Tommerup; C B van der Hagen; K Imaizumi; Y Kuroki; M J van den Boogaard; J M de Pater; E C Mariman; B C Hamel; H Himmelbauer; A M Frischauf; R Stallings; G C Beverstock; G J van Ommen; R C Hennekam
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

Review 5.  Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature.

Authors:  M M van Genderen; G F Kinds; F C Riemslag; R C Hennekam
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

6.  A Behavioural Assessment of Social Anxiety and Social Motivation in Fragile X, Cornelia de Lange and Rubinstein-Taybi Syndromes.

Authors:  Hayley Crawford; Joanna Moss; Laura Groves; Robyn Dowlen; Lisa Nelson; Donna Reid; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2020-01

7.  Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome.

Authors:  Cédric Galéra; Emmanuelle Taupiac; Sonia Fraisse; Sophie Naudion; Eva Toussaint; Caroline Rooryck-Thambo; Marie-Ange Delrue; Benoit Arveiler; Didier Lacombe; Manuel-Pierre Bouvard
Journal:  J Autism Dev Disord       Date:  2009-04-07

8.  The association of neural axis and craniovertebral junction anomalies with scoliosis in Rubinstein-Taybi syndrome.

Authors:  Carlo Giussani; Angelo Selicorni; Chiara Fossati; Pablo Ingelmo; Francesco Canonico; Andrea Landi; Andrea Trezza; Matteo Riva; Erik P Sganzerla
Journal:  Childs Nerv Syst       Date:  2012-08-23       Impact factor: 1.475

9.  Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.

Authors:  R C Hennekam; M Tilanus; B C Hamel; H Voshart-van Heeren; E C Mariman; S E van Beersum; M J van den Boogaard; M H Breuning
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

10.  Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse alphaA-crystallin locus in lens.

Authors:  Ying Yang; Louise V Wolf; Ales Cvekl
Journal:  J Mol Biol       Date:  2007-04-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.